In patients with symptomatic, severe primary tricuspid regurgitation (TR), transcatheter edge-to-edge repair (TEER) and isolated tricuspid valve surgery showed comparable 1-year survival, and TEER’s procedural safety and efficacy outcomes were sustained through 1 year, a new registry analysis shows.